Schreiner MediPharm will introduce Flexi-Cap Protect, a label-and-cap combination with additional protection features, to the US market at INTERPHEX 2016.
Schreiner MediPharm, a Germany-based provider of specialty pharmaceutical labeling solutions, will introduce its new Flexi-Cap Protect to the US market at INTERPHEX NYC, April 26-28 at the Jacob Javits Center in New York, NY, Booth No. 1053.
In addition to the label-and-cap combination in the original Flexi-Cap, the new product employs an additional cap that protects the bottom of bottles or vials against glass breakage and surface contamination. Flexi-Cap Protect’s label and two caps are applied without heat, so that the medicine’s properties are not impaired. The upper cap includes space for imprinting warning notices or codes for track-and-trace systems or for integrating near-field communication (NFC) inlays for interactive applications.
Flexi-Cap Protect was initially developed to contain cytostatics-highly potent substances that combat cancer cells but are extremely toxic for healthy cells. Therefore, it is imperative to protect packaging against surface contamination and glass breakage. Despite sophisticated advances in the filling and packaging processes for such pharmaceuticals, contamination of primary packaging cannot be completely avoided, and breakage of the glass containers that house them can have serious consequences.
Flexi-Cap Protect comprises a film cap positioned over the closed container. The label is applied without covering the peel-open tab of the opening strip. Once the strip is opened, the bottom part of the cap, together with the label, remains attached to the container. Attempting to remove the rest of the cap destroys the label, eliminating the possibility of unnoticed illegal reuse. Flexi-Cap enables flexible use with different container types, forms, and sizes.
Source: Schreiner MediPharm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.